International Patent: BIVALENT ANTIBODIES COMPRISING ANTI-EGFR AND ANTI-CDCP1 ANTIBODY REGIONS

GENEVA, July 2 -- INDUPRO LABS filed a patent application (US2025/060206) for “BIVALENT ANTIBODIES COMPRISING ANTI-EGFR AND ANTI-CDCP1 ANTIBODY REGIONS”. With publication no. WO/2026/136599, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....